A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

NCT06722729 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: KDT-3594
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.